Earningsreport

Q2/2024 6/30/2024 EPS -0.350 ZacksConsensus -0.340 ActVsEst (0.010) - Miss

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors